Cardiovascular Clinical Studies

This channel includes news and new technology innovations from cardiovascular clinical trials. These clinical studies include all cardiac subspecialties.

A recent study unveiled a novel sinus node ablation technique that provides a safe and effective treatment option for patients suffering from symptomatic, drug-resistant inappropriate sinus tachycardia (IST). Results of the Susruta-IST Registry were presented as a late-breaking clinical trial at Heart Rhythm 2021, the annual meeting of the Heart Rhythm Society (HRS). #HRS21 #HRS2021

News | EP Lab

New Hybrid Ablation Technique Safe and Effective Treatment for Patients With Inappropriate Sinus Tachycardia

August 3, 2021 – A recent study unveiled a novel sinus node ablation technique that provides a safe and effective ...

August 03, 2021

The Philips EPD Kodex system for the EP lab.

News | EP Lab

Economic Analysis of CABANA Trial Reveals Economic Benefits of Catheter Ablation Compared to Drug Therapy

August 3, 2021 – A new analysis of the Catheter Ablation vs. Antiarrhythmic Drug Therapy for Atrial Fibrillation (CABANA ...

August 03, 2021

BIO-AffectDX is a multi-center, observational study that will enroll HF patients with paroxysmal, persistent and long-standing persistent AF, and a standard CRT-D indication. The study will include up to 400 participants implanted with a Biotronik Acticor CRT-DX system.

News | Cardiac Resynchronization Therapy Devices (CRT)

New Study Aims to Show Effectiveness of CRT-D for Heart Failure Patients With Atrial Fibrillation

August 3, 2021 — In association with Heart Rhythm 2021, Biotronik announced first enrollments in the landmark BIO ...

August 03, 2021

The Orchestra BioMed BackBeat Cardiac Neuromodulation Therapy (CNT) system is implanted similar to a pacemaker to stimulate the sympathetic nerves to help reduce blood pressure.

News | EP Lab

Significant and Sustained Reduction in Blood Pressure in MODERATO II Trial Using BackBeat Cardiac Neuromodulation Therapy in Crossover Patients

August 3, 2021 — Long-term follow-up data on hypertensive patients from the control group of the MODERATO II study who ...

August 03, 2021

Results of the STROKE-VT trial showed direct oral anticoagulants (DOACs) are more effective than aspirin in reducing cerebrovascular events, including stroke in patients undergoing ventricular tachycardia ablation.

News | EP Lab

Oral Anticoagulants After Catheter Ablation Helps Reduce Stroke in High-Risk Patients

July 29, 2021 – Results of the STROKE-VT trial shows direct oral anticoagulants (DOACs) are more effective than aspirin ...

July 29, 2021

The devices compared in the study were the Bardy Carnation Ambulatory Monitor long-term continuous ECG system (left) and the BioGuardian MCT cardiac event monitor (right). #HRS21 #HRS2021 #HeartRhythm21

News | EP Lab

Human ECG Monitoring Outperforms AI Dependent Remote Cardiac Monitoring

July 29, 2021 – Results from a new clinical trial found human-oversight dependent continuous electrocardiography (ECG) ...

July 29, 2021

The BardyDx Carnation Ambulatory Monitor (CAM) is a P-wave centric wearable ambulatory cardiac patch monitoring and arrhythmia detection device.

News | Cardiac Diagnostics

Bardy Carnation Ambulatory Monitor Patch Decreases Diagnosis Time and Readmissions

July 29, 2021 — A recent clinical study from Overlake Medical Center utilizing the Bardy Diagnostics Carnation ...

July 29, 2021

Heart Rhythm Society, HRS, 2021 Late-Breaking Clinical Trials in Electrophysiology. #HRS #HRS2021 #HRS21 #Heartrhythm21

Feature | EP Lab

Heart Rhythm Society 2021 Late-Breaking Clinical Trials in Electrophysiology

July 28, 2021 — Here is the complete list of late-breaking clinical trials (LBCT) and links to articles on all of them ...

August 09, 2021

Schematic illustration of a pre-vascularized stem cell patch having multiple stem cell-laden bio-inks to encorage heart cell regrowth at infarct areas. With permission from Elsevier. Read the original article.Jinah Jang, Reprinted from Biomaterials, Vol 112, Jinah Jang et al., 3D printed complex tissue construct using stem cell-laden decellularized extracellular matrix bioinks for cardiac repair, Pages 264-274, Copyright (2017),

News | Medical 3-D Printing

Bioprinted 3D Cardiac Patches Could Reverse Scar Formation, Promote Myocardial Regeneration After Heart Attacks

July 27, 2021 -- Cardiovascular diseases account for 32% of global deaths. Myocardial infarction, or heart attacks, play ...

July 27, 2021

Medtronic announced new data from the landmark WRAP-IT study published in Heart Rhythm,[1] demonstrating a significantly lower infection risk for patients who develop hematomas after cardiac implantable electronic devices (CIEDs) when the Tyrx Absorbable Antibacterial Envelope is used at implant. The analysis showed an 82% reduction in major CIED infections among patients with the Tyrx Envelope who developed hematomas compared to patients in the control group who developed hematomas.

News | EP Lab

Tyrx Absorbable Antibacterial Envelope Effectively Reduces Infections in Cardiac Device Patients with Hematomas

July 27, 2021 — Medtronic announced new data from the landmark WRAP-IT study published in Heart Rhythm,[1] demonstrating ...

July 27, 2021

$An example of the Medis QCA angiography imaging derived fractional flow reserve (FFR) assessment. This technology removes the need for pressure wires and adenosine used in traditional FFR assessments of the coronary arteries.$

News | Cath Lab

Quantitative Flow Ratio (QFR) Study Looks at Impact on Appropriateness of Revascularization in the PIONEER-IV Trial

July 22, 2021 — Medis Medical Imaging is partnering with CORRIB Core Lab and Sinomed in randomized clinical trial of ...

July 22, 2021

New trial results from the international RAPID Trial show that administering a full dose of a standard blood thinner early to moderately ill hospitalized patients with COVID-19 could halt the thrombo-inflammation process and reduce the risk of severe disease and death. How to anticoagulate COVID patients. How to prevent thrombus in COVID patients.

Feature | Coronavirus (COVID-19)

Study Supports Early Anticoagulant Treatment to Reduce Death in Moderately Ill COVID-19 Patients

July 15, 2021 — COVID-19 is marked by heightened inflammation and abnormal clotting in the blood vessels, particularly ...

July 15, 2021

Videos | Structural Heart

VIDEO: Acurate neo2 TAVR Valve Performs Well in Latest Trials

Doctor Andreas Ruck, interventional cardiologist and head of the mitral/tricuspid program, Karolinska University ...

July 14, 2021

An example of a strain echo from the study showing reduced peak longitudinal/reservoir left atrial strain in a COVID-19 patient who developed atrial fibrillation during admission. Average left atrial strain here is 20% (normal should be above 38%).

News | Cardiovascular Ultrasound

Speckle Tracking Strain Echo May Predict Heart Complications From COVID-19

July 13, 2021 — Researchers at Johns Hopkins Medicine have shown that speckle-tracking strain echocardiograms may ...

July 14, 2021

The Xeltis synthetic polymer restorative pulmonary valve is implanted surgically and acts as a scaffold for the patient's own cells to proliferate. The valve and conduit then bioresorbs over time, leaving behind a new valve made from the patient's own cells. The hope is this will reduce or eliminate the need for numerous repeat surgeries as a pediatric patient grows.

Feature | Heart Valve Technology

Xeltis Begins Pivotal Trial for Pulmonary Valve That Grows With the Patient

July 8, 2021 – Xeltis announced it started the first pivotal trial for a synthetic polymer restorative pulmonary valve ...

July 08, 2021